It was marketed as Thelin by Encysive Pharmaceuticals until Pfizer purchased Encysive in February 2008.
On je bio u prodaji pod imenom Telin od strane Encisive Farmaceutikals, sve dok Pfizer nije kupio tu kompaniju februara 2008.